Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Naperiglipron (usan)
2. Ly3549492
3. Ly-3549492
4. Naperiglipron [usan]
5. 2572566-11-9
6. Bjn78tt46s
7. Chembl5944135
8. Schembl22830391
9. Schembl29562181
10. Gtpl14175
11. Yqf2518
12. Us11655242, Example 2
13. Bdbm603919
14. Example 2 [wo2020263695]
15. D13181
16. 1h-benzimidazole-6-carboxylic Acid, 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]-2-fluoro-5-methylphenyl]methyl]-1-[(2s)-2-oxetanylmethyl]-
17. 2-[[4-[6-[(4-cyano-2-fluoro-phenyl)methoxy]-2-pyridyl]-2-fluoro-5-methyl-phenyl]methyl]-3-[[(2s)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic Acid
18. 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]-2-fluoro-5-methylphenyl]methyl]-1-[(2s)-2-oxetanylmethyl]-1h-benzimidazole-6-carboxylic Acid
19. 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridyl]-2-fluoro-5-methylphenyl]methyl]-3-[[(2s)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic Acid
20. 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl]-2-fluoro-5-methylphenyl]methyl]-3-[[(2s)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic Acid
| Molecular Weight | 580.6 g/mol |
|---|---|
| Molecular Formula | C33H26F2N4O4 |
| XLogP3 | 5.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 110 |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
39
PharmaCompass offers a list of Naperiglipron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Naperiglipron manufacturer or Naperiglipron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naperiglipron manufacturer or Naperiglipron supplier.
A Naperiglipron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naperiglipron, including repackagers and relabelers. The FDA regulates Naperiglipron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naperiglipron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Naperiglipron supplier is an individual or a company that provides Naperiglipron active pharmaceutical ingredient (API) or Naperiglipron finished formulations upon request. The Naperiglipron suppliers may include Naperiglipron API manufacturers, exporters, distributors and traders.
Naperiglipron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naperiglipron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Naperiglipron GMP manufacturer or Naperiglipron GMP API supplier for your needs.
A Naperiglipron CoA (Certificate of Analysis) is a formal document that attests to Naperiglipron's compliance with Naperiglipron specifications and serves as a tool for batch-level quality control.
Naperiglipron CoA mostly includes findings from lab analyses of a specific batch. For each Naperiglipron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naperiglipron may be tested according to a variety of international standards, such as European Pharmacopoeia (Naperiglipron EP), Naperiglipron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naperiglipron USP).
